216 related articles for article (PubMed ID: 16410530)
21. IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients.
Okamoto H; Iikuni N; Kamitsuji S; Yoshio T; Minota S; Kamatani N
Rheumatology (Oxford); 2006 Feb; 45(2):232-4. PubMed ID: 16377728
[No Abstract] [Full Text] [Related]
22. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
23. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
[TBL] [Abstract][Full Text] [Related]
24. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.
Kozora E; Ellison MC; West S
Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786
[TBL] [Abstract][Full Text] [Related]
25. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
26. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
27. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
[TBL] [Abstract][Full Text] [Related]
29. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
30. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
[TBL] [Abstract][Full Text] [Related]
31. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging.
Bosma GP; Rood MJ; Huizinga TW; de Jong BA; Bollen EL; van Buchem MA
Arthritis Rheum; 2000 Nov; 43(11):2428-36. PubMed ID: 11083265
[TBL] [Abstract][Full Text] [Related]
32. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Tashimo A; Mitamura Y; Nagai S; Nakamura Y; Ohtsuka K; Mizue Y; Nishihira J
Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
34. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus.
Filley CM; Kozora E; Brown MS; Miller DE; West SG; Arciniegas DB; Grimm A; Zhang L
Cogn Behav Neurol; 2009 Mar; 22(1):38-44. PubMed ID: 19372769
[TBL] [Abstract][Full Text] [Related]
35. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis.
Baron P; Bussini S; Cardin V; Corbo M; Conti G; Galimberti D; Scarpini E; Bresolin N; Wharton SB; Shaw PJ; Silani V
Muscle Nerve; 2005 Oct; 32(4):541-4. PubMed ID: 15962273
[TBL] [Abstract][Full Text] [Related]
36. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.
Monteiro de Almeida S; Letendre S; Zimmerman J; Kolakowski S; Lazzaretto D; McCutchan JA; Ellis R
J Neuroimmunol; 2006 Oct; 179(1-2):180-5. PubMed ID: 16901548
[TBL] [Abstract][Full Text] [Related]
37. The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid.
Letendre S; Marquie-Beck J; Singh KK; de Almeida S; Zimmerman J; Spector SA; Grant I; Ellis R;
J Neuroimmunol; 2004 Dec; 157(1-2):193-6. PubMed ID: 15579297
[TBL] [Abstract][Full Text] [Related]
38. Association between anti-U1 ribonucleoprotein antibodies and inflammatory mediators in cerebrospinal fluid of patients with neuropsychiatric systemic lupus erythematosus.
Yokoyama T; Fujii T; Kondo-Ishikawa S; Yamakawa N; Nakano M; Yukawa N; Yoshifuji H; Ohmura K; Mimori T
Lupus; 2014 Jun; 23(7):635-42. PubMed ID: 24493282
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
40. Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
Rovin BH; Song H; Birmingham DJ; Hebert LA; Yu CY; Nagaraja HN
J Am Soc Nephrol; 2005 Feb; 16(2):467-73. PubMed ID: 15601744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
